SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc.
MNTA 52.480.0%Oct 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (3022)2/13/2018 2:41:10 PM
From: tuck  Read Replies (1) of 3027
 
And TEVA was too optimistic: 40Mg Glatopa approved and launched. So telegraphed and priced in that there's no reaction. That market will go the way of Lovenox. Have been out of MNTA for several months, and haven't really followed it closely. Will keep on eye on it for its pipe, but at the moment I'm not aware of any readouts that could move the stock in the next year. Anybody?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext